92 related articles for article (PubMed ID: 6198972)
1. Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Improved sensitivity for detecting epidermal cancer cells.
Robinson JK; Gottschalk R
Arch Dermatol; 1984 Feb; 120(2):199-203. PubMed ID: 6198972
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinoma: rapid techniques using cytokeratin markers to assist treatment by micrographic (Mohs') surgery.
Ramnarain ND; Walker NP; Markey AC
Br J Biomed Sci; 1995 Sep; 52(3):184-7. PubMed ID: 8527995
[TBL] [Abstract][Full Text] [Related]
3. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody labelling the keratinocyte membrane: a marker of epidermal differentiation.
Viac J; Haftek M; Staquet MJ; Reano A; Brochier J; Thivolet J
Acta Derm Venereol; 1985; 65(1):1-8. PubMed ID: 2578699
[TBL] [Abstract][Full Text] [Related]
5. Use of a murine monoclonal antibody which binds to malignant keratinocytes to detect tumor cells in microscopically controlled surgery.
Oseroff AR; Roth R; Lipman S; Morhenn VB
J Am Acad Dermatol; 1983 May; 8(5):616-9. PubMed ID: 6345603
[TBL] [Abstract][Full Text] [Related]
6. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
7. [Study of normal and pathological keratinization using anti-keratin polypeptide sera (author's transl)].
Thivolet J; Viac J; Staquet MJ; Schmitt D
Ann Dermatol Venereol; 1980 May; 107(5):357-64. PubMed ID: 6164332
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of keratin in normal human tissues.
Schlegel R; Banks-Schlegel S; Pinkus GS
Lab Invest; 1980 Jan; 42(1):91-6. PubMed ID: 6986004
[TBL] [Abstract][Full Text] [Related]
9. [The localization of structurally specific antigens in squamous cell skin cancer using monoclonal antibodies to epidermal antigens].
Kogan MG; Berenbeĭn BA; Drobyshevskaia EI; Abyzov VN; Spitsin SV
Vopr Onkol; 1989; 35(9):1032-6. PubMed ID: 2479174
[TBL] [Abstract][Full Text] [Related]
10. [Patterns of keratin protein expression in basal cell, metatypical and squamous cell carcinoma of human skin].
Karelina TV; Kazantseva IA
Arkh Patol; 1991; 53(4):29-32. PubMed ID: 1714712
[TBL] [Abstract][Full Text] [Related]
11. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways.
Leers MP; Theunissen PH; Koudstaal J; Schutte B; Ramaekers FC
Cytometry; 1997 Feb; 27(2):179-88. PubMed ID: 9012385
[TBL] [Abstract][Full Text] [Related]
12. Current concepts: the use of immunoperoxidase techniques in mohs micrographic surgery.
Mondragon RM; Barrett TL
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):66-71. PubMed ID: 10863226
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of keratin in human adenocarcinomas.
Ramaekers F; Puts J; Moesker O; Kant A; Jap P; Vooijs P
Am J Pathol; 1983 May; 111(2):213-23. PubMed ID: 6189402
[TBL] [Abstract][Full Text] [Related]
14. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
Cronin WJ; Dorsett BH; Ioachim HL
Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
[TBL] [Abstract][Full Text] [Related]
15. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescent localization of cytokeratin intermediate filaments as a means of defining the presence of recurrent basal cell carcinoma.
Ronnen M; Suster S; Orenstein A
Cutis; 1988 Oct; 42(4):359-62. PubMed ID: 2466615
[TBL] [Abstract][Full Text] [Related]
17. Antikeratin antibodies in routine diagnostic pathology. A comparison of 10 different commercial antikeratins.
Mygind H; Nielsen B; Moe D; Clausen H; Dabelsteen E; Clausen PP
APMIS; 1988 Nov; 96(11):1009-22. PubMed ID: 2461716
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control.
Marra DE; Schanbacher CF; Torres A
Dermatol Surg; 2004 May; 30(5):799-802. PubMed ID: 15099329
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antikeratin antibody: production, characterization, and immunohistochemical application.
Eto H; Hashimoto K; Kobayashi H; Matsumoto M; Kanzaki T; Mehregan AH; Weiss RA
J Invest Dermatol; 1985 May; 84(5):404-9. PubMed ID: 2582061
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
